MXPA02012176A - Un metodo para detectar un complejo de liproproteina -proteina de fase aguda y predecir un riesgo mayor de falla de sistema o mortalidad. - Google Patents
Un metodo para detectar un complejo de liproproteina -proteina de fase aguda y predecir un riesgo mayor de falla de sistema o mortalidad.Info
- Publication number
- MXPA02012176A MXPA02012176A MXPA02012176A MXPA02012176A MXPA02012176A MX PA02012176 A MXPA02012176 A MX PA02012176A MX PA02012176 A MXPA02012176 A MX PA02012176A MX PA02012176 A MXPA02012176 A MX PA02012176A MX PA02012176 A MXPA02012176 A MX PA02012176A
- Authority
- MX
- Mexico
- Prior art keywords
- patient
- acute phase
- lipoprotein
- phase protein
- mortality
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/557—Immunoassay; Biospecific binding assay; Materials therefor using kinetic measurement, i.e. time rate of progress of an antigen-antibody interaction
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Endocrinology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Abstract
Un metodo para diagnosticar una condicion de un paciente incluye los pasos de (a) agregar uno o mas reactivos a una muestra de prueba de un paciente, las muestras de prueba comprendiendo por lo menos parte de una muestra de sangre del paciente, para ocasionar la formacion de un complejo que comprende por lo menos una proteina de fase aguda y por lo menos una lipoproteina humana, sin causar sustancialmente polimerizacion de fibrina; (b) medir la formacion del complejo con respecto al tiempo, a fin de derivar un perfil de medicion dependiente del tiempo; y (c) determinar una pendiente y/o cambio total en el perfil de medicion dependiente del tiempo, a fin de diagnosticar una condicion del paciente; una mayor formacion del complejo se correlaciona con mayor probabilidad de muerte del paciente.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US59164200A | 2000-06-09 | 2000-06-09 | |
PCT/US2001/018611 WO2001096864A2 (en) | 2000-06-09 | 2001-06-08 | A method for detecting a lipoprotein-acute phase protein complex |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA02012176A true MXPA02012176A (es) | 2004-08-19 |
Family
ID=26680497
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA02012176A MXPA02012176A (es) | 2000-06-09 | 2001-06-08 | Un metodo para detectar un complejo de liproproteina -proteina de fase aguda y predecir un riesgo mayor de falla de sistema o mortalidad. |
Country Status (10)
Country | Link |
---|---|
US (1) | US20070155018A1 (es) |
EP (1) | EP1309857B1 (es) |
JP (1) | JP5051960B2 (es) |
AT (1) | ATE302947T1 (es) |
AU (2) | AU6679501A (es) |
BR (1) | BR0111987A (es) |
CA (1) | CA2412317C (es) |
DE (1) | DE60112949T2 (es) |
MX (1) | MXPA02012176A (es) |
WO (1) | WO2001096864A2 (es) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1476752A4 (en) | 2002-02-27 | 2008-02-13 | Bio Merieux Inc | METHOD FOR DIAGNOSING AND MONITORING HEMOSTATIC DYSFUNCTION, SEVERE INFECTION AND SYSTEMATIC INFLAMMATORY RESPONSE SYNDROME |
CA2505921A1 (en) | 2002-11-12 | 2004-05-27 | Becton, Dickinson And Company | Diagnosis of sepsis or sirs using biomarker profiles |
MXPA05005072A (es) | 2002-11-12 | 2005-07-22 | Becton Dickinson Co | Diagnostico de la sepsis o sirs usando perfiles de biomarcadores. |
WO2006060386A1 (en) * | 2004-12-01 | 2006-06-08 | Biomerieux, Inc. | Method for diagnosing critically ill patients |
BRPI0609302A2 (pt) | 2005-04-15 | 2011-10-11 | Becton Dickinson Co | métodos para prever o desenvolvimento de sepse e para diagnosticar sepse em um indivìduo a ser testado, microarranjo, kit para prever o desenvolvimento de sepse em um indivìduo a ser testado, produto de programa de computador, computador, sistema de computador para determinar se um indivìduo é susceptìvel de desenvolver sepse, sinal digital embutido em uma onda portadora, e, interface gráfica de usuário para determinar se um indivìduo é susceptìvel de desenvolver sepse |
JP5125608B2 (ja) * | 2008-02-28 | 2013-01-23 | 東ソー株式会社 | イオン交換クロマトグラフィーによる血液中のLp(a)の分離方法 |
WO2009123737A2 (en) | 2008-04-03 | 2009-10-08 | Becton, Dickinson And Company | Advanced detection of sepsis |
GB201223079D0 (en) | 2012-12-20 | 2013-02-06 | Sepsis Ltd | Point of care sepsis assay device and method |
GB201301611D0 (en) | 2013-01-30 | 2013-03-13 | Shaw Andrew M | Systems and methods for medical data processing and analysis |
GB202004047D0 (en) | 2020-03-20 | 2020-05-06 | Ainger Phill | Point of care sepsis assay device and method |
CN113252852B (zh) * | 2021-06-04 | 2021-10-22 | 金科环境股份有限公司 | 絮凝剂性能评价与检验设备及方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5708591A (en) * | 1995-02-14 | 1998-01-13 | Akzo Nobel N.V. | Method and apparatus for predicting the presence of congenital and acquired imbalances and therapeutic conditions |
US6429017B1 (en) * | 1999-02-04 | 2002-08-06 | Biomerieux | Method for predicting the presence of haemostatic dysfunction in a patient sample |
-
2001
- 2001-06-08 BR BR0111987-7A patent/BR0111987A/pt not_active IP Right Cessation
- 2001-06-08 CA CA2412317A patent/CA2412317C/en not_active Expired - Fee Related
- 2001-06-08 AU AU6679501A patent/AU6679501A/xx active Pending
- 2001-06-08 AT AT01944378T patent/ATE302947T1/de not_active IP Right Cessation
- 2001-06-08 EP EP01944378A patent/EP1309857B1/en not_active Expired - Lifetime
- 2001-06-08 WO PCT/US2001/018611 patent/WO2001096864A2/en active IP Right Grant
- 2001-06-08 MX MXPA02012176A patent/MXPA02012176A/es active IP Right Grant
- 2001-06-08 JP JP2002510942A patent/JP5051960B2/ja not_active Expired - Fee Related
- 2001-06-08 AU AU2001266795A patent/AU2001266795B2/en not_active Ceased
- 2001-06-08 DE DE60112949T patent/DE60112949T2/de not_active Expired - Lifetime
-
2007
- 2007-02-19 US US11/676,483 patent/US20070155018A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20070155018A1 (en) | 2007-07-05 |
BR0111987A (pt) | 2003-10-28 |
EP1309857B1 (en) | 2005-08-24 |
EP1309857A2 (en) | 2003-05-14 |
JP5051960B2 (ja) | 2012-10-17 |
AU6679501A (en) | 2001-12-24 |
ATE302947T1 (de) | 2005-09-15 |
WO2001096864A2 (en) | 2001-12-20 |
DE60112949D1 (de) | 2005-09-29 |
JP2004503254A (ja) | 2004-02-05 |
AU2001266795B2 (en) | 2006-07-13 |
WO2001096864A3 (en) | 2003-02-06 |
CA2412317A1 (en) | 2001-12-20 |
CA2412317C (en) | 2016-03-22 |
DE60112949T2 (de) | 2006-05-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0981048A3 (en) | Blood clot detector | |
DE69910003D1 (de) | Überwachung physiologischer analyte | |
HUP9701607A2 (hu) | Eljárás és készülék kémiai összetevőnek anyagmintából, különösen vér glükóztartalmának vérmintából történő meghatározásához | |
WO2003043487A3 (en) | Method of using a non-antibody protein to detect and measure an analyte | |
DE60128249D1 (de) | Verfahren zur diagnose von immunologischer lebensmittelsensitivität | |
DE69910007D1 (de) | Vorrichtung zum vorhersagen von physiologischen messwerten | |
DE60238814D1 (de) | Integriertes blutprobemessgerät mit teststreifen | |
ATE241933T1 (de) | Verfahren und vorrichtung zum vorhersagen von physiologischen messwerten | |
BG104275A (en) | Method and device for express analysis of tested parameters in biological samples | |
WO2002015458A3 (en) | Discovering hidden damage in machinery and predicting remaining life | |
ATE509275T1 (de) | Schnelltest für glykiertes albumin | |
AU6679501A (en) | A method for detecting a lipoprotein-acute phase protein complex and predicting an increased risk of system failure or mortality | |
EA202192954A1 (ru) | Электрохимическое измерение d-лактата для диагностики и прогнозирования инфекционного заболевания | |
NO20062280L (no) | Test | |
JP2021510815A5 (es) | ||
DE60025170D1 (de) | Diagnostisches verfahren für asthma | |
EP0992213A1 (en) | Method for calibration and measurement in a micro-dialysis system | |
AU768436B2 (en) | Method and apparatus for presenting thrombosis and hemostasis assay data | |
US20040219680A1 (en) | Method and apparatus for determining anticoagulant therapy factors | |
AU2001270968A1 (en) | Conductivity-normalized urinary analyte concentration measurement for use in disease diagnosis | |
DK1393078T3 (da) | Fremgangsmåder til diagnosticering in vitro eller til overvågning af en sygdom involverende en inflammatorisk reaktion | |
IL143639A0 (en) | Method for determining the activity of a substance using a functional test in vitro | |
JPS60165552A (ja) | 生化学自動分析装置 | |
WO2002077275A3 (en) | Diagnostic method for determining abnormality of cloned embryos | |
ATE140798T1 (de) | Lipid-abhängige diagnostische analysenverfahren |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |